• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/10/21 3:17:50 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology
    Get the next $BDR alert in real time by email
    SC 13G/A 1 cavalry_blonder13g.htm SC 13G Schedule 13G/A

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549


    SCHEDULE 13G


    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*


    Blonder Tongue Laboratories, Inc.

    (Name of Issuer)


    Common Stock, $0.001 par value

    (Title of Class of Securities)


    093698 108

    (CUSIP Number)



    January 26, 2021

    (Date of Event which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:


     

     Rule 13d-1(b)

     

     

    ü

     Rule 13d-1(c)

     

     

     

     Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section of the Exchange Act but shall be subject to all other provisions of the Exchange Act (however, see the Notes).

     




    CUSIP No. 093698 108                                             13G                                                  Page 2 of 7 Pages




    1

    NAME OF REPORTING PERSON


    Cavalry Fund I LP

     

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)   ¨

    (b)   ¨

     

    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

    5

    SOLE VOTING POWER

     

    578,495 (1)

     

     

    6

    SHARED VOTING POWER (see Item 5 below)


    0

     

     

    7

    SOLE DISPOSITIVE POWER

     

    578,495 (1)

     

     

    8

    SHARED DISPOSITIVE POWER (see Item 5 below)


    0

     

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON


    578,495 (1)

     

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES


    þ (2)

     

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)


    4.99%

     

    12

    TYPE OF REPORTING PERSON


    OO

     





    CUSIP No. 093698 108                                             13G                                                  Page 3 of 7 Pages




    1

    NAME OF REPORTING PERSON


    Cavalry Fund I Management LLC

     

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)   ¨

    (b)   ¨

     

    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

    5

    SOLE VOTING POWER

     

    578,495 (1)

     

     

    6

    SHARED VOTING POWER (see Item 5 below)


    0

     

     

    7

    SOLE DISPOSITIVE POWER

     

    578,495 (1)

     

     

    8

    SHARED DISPOSITIVE POWER (see Item 5 below)


    0

     

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON


    578,495 (1)

     

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES


    þ (2)

     

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)


    4.99%

     

    12

    TYPE OF REPORTING PERSON


    OO

     





    CUSIP No. 093698 108                                             13G                                                  Page 4 of 7 Pages




    1

    NAME OF REPORTING PERSON


    Thomas Walsh

     

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)   ¨

    (b)   ¨

     

    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

     

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

    5

    SOLE VOTING POWER

     

    578,495 (1)

     

     

    6

    SHARED VOTING POWER (see Item 5 below)


    0

     

     

    7

    SOLE DISPOSITIVE POWER

     

    578,495 (1)

     

     

    8

    SHARED DISPOSITIVE POWER (see Item 5 below)


    0

     

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON


    578,495 (1)

     

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES


    þ (2)

     

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)


    4.99%

     

    12

    TYPE OF REPORTING PERSON


    IN

     


    (1)

    Represents (i) 201,718 shares of common stock and (ii) 376,777 shares of common stock issuable upon exercise of warrants (see footnote 2) held by Cavalry Fund I LP. Cavalry Fund I Management LLC is the general partner of Cavalry Fund I LP. Thomas Walsh is the Manager of Cavalry Fund I Management LLC. As such, Cavalry Fund I Management LLC and Mr. Walsh may be deemed to beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) 578,495 shares of common stock. To the extent Mr. Walsh is deemed to beneficially own such shares, Mr. Walsh disclaims beneficial ownership of these securities for all other purposes.

    (2)

    In addition to the 201,718 shares of common stock held by Cavalry Fund I LP, Cavalry Fund I LP also owns (i) a warrant to purchase 625,000 shares of common stock, only a portion of which is currently exercisable due to a beneficial ownership limitation of 4.99% of the Company’s issued and outstanding common stock, and (ii) a convertible promissory note that is convertible into 400,263 shares of common stock (excluding shares that may be issuable upon conversion of any interest payable thereunder), only a portion of which is currently convertible due to a beneficial ownership limitation of 4.99% of the Company’s issued and outstanding common stock.






    CUSIP No. 093698 108                                             13G                                                  Page 5 of 7 Pages




    Item 1(a).

    Name of Issuer

     

     

     

    Blonder Tongue Laboratories, Inc.

     

     

    Item 1(b).

    Address of the Issuer’s Principal Executive Offices

     

     

     

    One Jake Brown Road, Old Bridge, New Jersey 08857

     

    Item 2(a).

    Names of Persons Filing

     

     

     

    This Statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”):

     

     

    (i)

    Cavalry Fund I LP

     

     

     

     

    (ii)

    Cavalry Fund I Management LLC

     

     

    (iii)

    Thomas Walsh

     

    Item 2(b).

    Address of the Principal Business Office, or if none, Residence:

     

     

     

    The address for each Reporting Person is 61 82 E. Allendale Rd. Ste 5B, Saddle River, NJ 07458.

     

     

    Item 2(c).

    Citizenship

     

     

    Cavalry Fund I LP is a limited partnership formed under the laws of Delaware.

     

     

     

    Cavalry Fund I Management LLC is a limited liability company formed under the laws of Delaware.

     

     

     

    Thomas Walsh is a citizen of the United States.

     

    Item 2(d).

    Title of Class of Securities

     

     

     

    Common Stock, $0.001 par value (“Common Stock”)

     

    Item 2(e).

    CUSIP Number

     

     

     

    093698 108


    Item 3.

    If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

     

     

    (a)  Broker or Dealer registered under Section 15 of the Exchange Act.

     

     

     

    (b) Bank as defined in Section 3(a)(b) or the Exchange Act.

     

     

     

    (c) Insurance company as defined in Section 3(a)(19) of the Exchange Act.

     

     

     

    (d) Investment company registered under Section 8 of the Investment Company Act.

     

     

     

    (e) An Investment adviser in accordance with Rule 13d-1 (b)(1)(ii)(e).

     

     

     

    (f)  An employee benefit plan or endowment fund in accordance with Rule 13d 1(b)(1)(ii)(f).

     

     

     

    (g) A Parent Holding Company or control person in accordance with Rule 13d 1(b)(1)(ii)(g).

     

     

     

    (h) A Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act.

     

     

     

    (i) A Church Plan that is excluded from the definition of an investment company under Section 3 (c)(14) of the Investment Company Act.




    CUSIP No. 093698 108                                             13G                                                  Page 6 of 7 Pages




     

    (j) Group, in accordance with Rule 13d-1 (b)(1)(ii)(j).

     

     

     

    Not applicable


    Item 4.

    Ownership

     

     

    (a)

    The responses to Items 5-11 of the cover pages of this Schedule 13G/A are incorporated herein by reference.

     

     

    (b)

    The percentage set forth on Row (11) of the cover page for each Reporting Person is based on 11,593,105 shares of Common Stock outstanding as of February 2, 2021.

     

     

    (c)

    Cavalry Fund I Management LLC is the general partner of Cavalry Fund I LP, and Thomas Walsh is the Manager of Cavalry Fund I Management LLC. As such, Cavalry Fund I Management LLC and Mr. Walsh may be deemed to beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) 578,495 shares of Common Stock. To the extent Mr. Walsh is deemed to beneficially own such shares, Mr. Walsh disclaims beneficial ownership of these securities for all other purposes.

     

     

    (d)

    The Reporting Person owns 201,718 shares of Common Stock. The Reporting Person also owns (i) a warrant to purchase 625,000 shares of common stock, only a portion of which is currently exercisable due to a beneficial ownership limitation of 4.99% of the Company’s issued and outstanding common stock, and (ii) a convertible promissory note that is convertible into 400,263 shares of common stock (excluding shares that may be issuable upon conversion of any interest payable thereunder), only a portion of which is currently convertible due to a beneficial ownership limitation of 4.99% of the Company’s issued and outstanding common stock.

     

    Item 5.

    Ownership of Five Percent or Less of a Class

     

     

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following þ.

     

     

    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person

     

     

     

    Not Applicable 

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

     

     

     

    Not Applicable

     

     

    Item 8.

    Identification and Classification of Members of the Group

     

     

     

    Not Applicable

     

     

    Item 9.

    Notice of Dissolution of Group

     

     

     

    Not Applicable

     

     

    Item 10.

    Certification

     

     

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.





    CUSIP No. 093698 108                                             13G                                                  Page 7 of 7 Pages



    SIGNATURE


    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


     

    Cavalry Fund I LP

     Date: February 10, 2021

    By: Cavalry Fund I Management LLC,

    its General Partner

     

     

     

     

    By:

    /s/ Thomas Walsh

     

     

    Name: Thomas Walsh

     

     

    Title: Manager


     

    Cavalry Fund I Management LLC

     

     

     Date: February 10, 2021

    By:

    /s/ Thomas Walsh

     

     

    Name: Thomas Walsh

     

     

    Title: Manager

     

     

     

     

     

     

     

     

     Date: February 10, 2021

    By:

    /s/ Thomas Walsh

     

     

    Thomas Walsh

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     






    Get the next $BDR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BDR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BDR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Skolnik Eric S was granted 2,783 shares, increasing direct ownership by 3% to 99,012 units

    4 - BLONDER TONGUE LABORATORIES INC (0001000683) (Issuer)

    1/3/23 4:28:01 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    SEC Form 4: Horvath Allen was granted 2,024 shares, increasing direct ownership by 1% to 165,906 units

    4 - BLONDER TONGUE LABORATORIES INC (0001000683) (Issuer)

    1/3/23 4:27:15 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    SEC Form 4: Grauch Edward Rowland was granted 5,466 shares, increasing direct ownership by 0.47% to 1,161,000 units

    4 - BLONDER TONGUE LABORATORIES INC (0001000683) (Issuer)

    1/3/23 4:26:03 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $BDR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Blonder Tongue Laboratories Releases Clearview HEVC Video Transcoder

    Offering Broadcasters, Satellite and Cable Operators a Migration Path to Ultra Low Bandwidth Video DeliveryOLD BRIDGE, NJ / ACCESSWIRE / June 8, 2022 / Blonder Tongue Laboratories, Inc. (NYSE:BDR), a leading US-based designer and manufacturer of video and data transmission technologies, announced the release of their new ClearviewTM HEVC advanced IP video transcoder for use by broadcasters, satellite and cable television service providers currently in the process or planning a transition to the latest MPEG HEVC/H.265 international standard for video compression. The Clearview HEVC allows those broadcasters and service providers a cost-effective path to support all end customers requiring dig

    6/8/22 7:30:00 AM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Blonder Tongue Laboratories Announces Advanced Rack Mount Broadband Distribution Amplifier

    New RMDA 1000 offers expanded Bandwidth and FlexibilityOLD BRIDGE, NJ / ACCESSWIRE / May 23, 2022 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR) today announced the release of its newest Rack-Mount Distribution Amplifier (RMDA), the RMDA 1000-42P, expanding on its best-selling broadband amplifier series. The RMDA 1000 is a completely self-contained high gain, 1 Gigahertz amplifier designed specifically for HFC signal distribution systems requiring low distortion characteristics.The RMDA 1000-42P has expanded bandwidth supporting up to 1002 MHz, with a 42dB high-gain design, making it useful in systems which use direct cable-drops as a signal source, or as the launch amplifier in a h

    5/23/22 8:00:00 AM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Blonder Tongue Reports First Quarter 2022 Results

    OLD BRIDGE, NJ / ACCESSWIRE / May 6, 2022 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR) announced its sales and results for the first quarter ended March 31, 2022.Blonder Tongue Laboratories, Inc. net sales increased $90,000 or 2.8% to $3,341,000 for the first quarter of 2022 from $3,251,000 for the comparable period in 2021. Net loss for the three months ended March 31, 2022 was $(1,154,000) or $(0.09) per share, compared to $(414,000) or $(0.04) per share for the comparable period in 2021.Commenting on the Company's first quarter results, Chief Executive Officer Ted Grauch noted, "Despite continued strong demand for Blonder Tongue Laboratories' Clearview and Drake video encoding

    5/6/22 8:00:00 AM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $BDR
    SEC Filings

    View All

    Blonder Tongue Laboratories Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - BLONDER TONGUE LABORATORIES INC (0001000683) (Filer)

    1/23/23 5:10:39 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Blonder Tongue Laboratories Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - BLONDER TONGUE LABORATORIES INC (0001000683) (Filer)

    1/6/23 4:25:17 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    SEC Form 10-Q filed by Blonder Tongue Laboratories Inc.

    10-Q - BLONDER TONGUE LABORATORIES INC (0001000683) (Filer)

    11/4/22 4:15:58 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $BDR
    Financials

    Live finance-specific insights

    View All

    Blonder Tongue Reports First Quarter 2022 Results

    OLD BRIDGE, NJ / ACCESSWIRE / May 6, 2022 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR) announced its sales and results for the first quarter ended March 31, 2022.Blonder Tongue Laboratories, Inc. net sales increased $90,000 or 2.8% to $3,341,000 for the first quarter of 2022 from $3,251,000 for the comparable period in 2021. Net loss for the three months ended March 31, 2022 was $(1,154,000) or $(0.09) per share, compared to $(414,000) or $(0.04) per share for the comparable period in 2021.Commenting on the Company's first quarter results, Chief Executive Officer Ted Grauch noted, "Despite continued strong demand for Blonder Tongue Laboratories' Clearview and Drake video encoding

    5/6/22 8:00:00 AM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Blonder Tongue Schedules Conference Call to Discuss First Quarter 2022 Earnings Results

    OLD BRIDGE, NJ / ACCESSWIRE / April 28, 2022 / Blonder Tongue Laboratories, Inc. (NYSE:BDR) announced today it will report its First Quarter 2022 Earnings Results on Friday, May 6, 2022 prior to market opening. Management will then host a teleconference to discuss the results with the investment community.Details of the live teleconference:Date: Friday, May 6, 2022Time: 11:00 a.m. Eastern Time (10:00 a.m. CT, 8:00 a.m. PT)Toll Free: 888-506-0062International: 973-528-0011 Participant Access Code: 329982The audio replay will be available under Investor Related Information on the Blonder Tongue Investor Relations webpage.About Blonder Tongue LabsBlonder Tongue Laboratories, Inc. is the oldest

    4/28/22 4:05:00 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Blonder Tongue Reports Year End and Fourth Quarter 2021 Results

    OLD BRIDGE, NJ / ACCESSWIRE / March 31, 2022 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR) announced its sales and results for the fourth quarter and year ended December 31, 2021.Commenting on the Company's year end and fourth quarter results, Chief Executive Officer Ted Grauch noted, "Although the Company was able to realize positive net earnings for the full year of 2021, the global semiconductor supply chain bottlenecks and supply uncertainties had a significant negative impact on our fourth quarter financial performance, and a number of those supply chain issues have continued into this year. We have been managing through this challenging environment with a combination of produ

    3/31/22 8:15:00 AM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $BDR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Blonder Tongue Laboratories, Inc. (Amendment)

    SC 13G/A - BLONDER TONGUE LABORATORIES INC (0001000683) (Subject)

    10/13/21 7:30:11 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    SEC Form SC 13G/A filed

    SC 13G/A - BLONDER TONGUE LABORATORIES INC (0001000683) (Subject)

    2/10/21 3:17:50 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology